Vaccitech plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, revenue was USD 38.25 million compared to USD 0.269 million a year ago. Net income was USD 26.53 million compared to net loss of USD 35.75 million a year ago. Basic earnings per share from continuing operations was USD 0.71 compared to basic loss per share from continuing operations of USD 1.58 a year ago. Diluted earnings per share from continuing operations was USD 0.69 compared to diluted loss per share from continuing operations of USD 1.58 a year ago.